AMGN
59
12
PX
50
2
AKAM
58
2
PYPL
37
4
SYF
88
3
JCI
33
-2
AN
44
-6
WU
32
2
DG
32
2
EOG
46
5
MTB
57
8
ITW
64
2
KO
49
-3
NWSA
80
-4
NWS
69
-2
MAS
50
-4
DO
45
-2
PNC
42
-3
AA
34
3
ABT
57
7
AMGN
59
12
PX
50
2
AKAM
58
2
PYPL
37
4
SYF
88
3
JCI
33
-2
AN
44
-6
WU
32
2
DG
32
2
EOG
46
5
MTB
57
8
ITW
64
2
KO
49
-3
NWSA
80
-4
NWS
69
-2
MAS
50
-4
DO
45
-2
PNC
42
-3
AA
34
3
ABT
57
7
Financhill
Back

MidCap Financial Investment Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
37

MFIC
MidCap Financial Investment

Last Price:
15.02
Seasonality Move:
1.08%
Sell
38

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
37
MidCap Financial Investment (MFIC) is a Sell

Is MidCap Financial Investment a Buy, Sell or Hold?

  • The current MidCap Financial Investment [MFIC] share price is $15.10. The Score for MFIC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • MFIC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MFIC Stock Price Chart

What is MidCap Financial Investment's stock price today?

  • The MidCap Financial Investment share price today is $15.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MFIC is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $38.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

MFIC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 40 Sell
Chaikin Money Flow: -198940 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.26 - 15.92) Sell
Bollinger Bands (100): (14.28 - 15.54) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 40.05 Sell
Chaikin Money Flow: 76134 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.06 - 42.34) Sell
Bollinger Bands (100): (41.13 - 48.85) Sell

MFIC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.32 Sell
20-day SMA: 15.6 Sell
50-day SMA: 15.41 Sell
200-day SMA: 14.18 Buy
8-day EMA: 15.34 Sell
20-day EMA: 15.49 Sell
50-day EMA: 15.35 Sell
200-day EMA: 14.34 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.68 Sell
20-day SMA: 40.48 Sell
50-day SMA: 42.18 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.81 Sell
20-day EMA: 40.64 Sell
50-day EMA: 42.13 Sell
200-day EMA: 43.5 Sell

MidCap Financial Investment Earnings Growth & MFIC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.05 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

MidCap Financial Investment Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):